Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-term Observational Study in Participants Who Have Received PBGENE-HBV
Sponsor: Precision BioSciences, Inc.
Summary
Participants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.
Official title: A Long-term Observational Study in Participants Who Have Received PBGENE-HBV, an In Vivo Gene Editing Investigational Product, in a Prior Clinical Study
Key Details
Gender
All
Age Range
19 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
45
Start Date
2025-12-25
Completion Date
2040-06
Last Updated
2026-04-22
Healthy Volunteers
No
Conditions
Interventions
PBGENE-HBV
PBGENE-HBV is the investigational product administered in the parent study. This LTFU study is non-interventional; no investigational product given.
Locations (4)
Massachusetts General Hospital/Harvard University
Boston, Massachusetts, United States
Queen Mary Hospital, University of Hong Kong
Hong Kong, Hong Kong, Hong Kong
ICS ARENSIA Exploratory Medicine SRL
Chisinau, Moldova, Moldova
New Zealand Clinical Research
Auckland, New Zealand, New Zealand